These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3050411)

  • 41. Psychopharmacologic treatment of obsessive-compulsive disorder.
    Thorneloe WF
    J Med Assoc Ga; 1988 Nov; 77(11):825-6. PubMed ID: 3057098
    [No Abstract]   [Full Text] [Related]  

  • 42. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoxetine-clomipramine interaction.
    Sternbach H
    J Clin Psychiatry; 1995 Apr; 56(4):171-2. PubMed ID: 7713858
    [No Abstract]   [Full Text] [Related]  

  • 44. Clomipramine in phobic and obsessional states: preliminary report.
    Silva FR; Wijewickrama HS
    N Z Med J; 1976 Jul; 84(567):4-6. PubMed ID: 1067503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder.
    Leonard HL; Swedo SE; Lenane MC; Rettew DC; Cheslow DL; Hamburger SD; Rapoport JL
    Arch Gen Psychiatry; 1991 Oct; 48(10):922-7. PubMed ID: 1929762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous clomipramine for obsessive-compulsive disorder.
    Koran LM; Faravelli C; Pallanti S
    J Clin Psychopharmacol; 1994 Jun; 14(3):216-8. PubMed ID: 8027426
    [No Abstract]   [Full Text] [Related]  

  • 47. The psychopharmacological treatment of obsessive-compulsive disorder: a review.
    Insel TR; Murphy DL
    J Clin Psychopharmacol; 1981 Sep; 1(5):304-11. PubMed ID: 6174553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.
    Kasvikis Y; Marks IM
    Psychopharmacology (Berl); 1988; 95(1):113-8. PubMed ID: 3133689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonin and effect sizes of antiobsessive agents.
    Pato MT; Gluhoski V
    Am J Psychiatry; 1992 Mar; 149(3):420-1. PubMed ID: 1531582
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clomipramine in the treatment of obsessive-compulsive neuroses].
    Hartelius H
    Lakartidningen; 1975 Mar; 72(10):973. PubMed ID: 1128031
    [No Abstract]   [Full Text] [Related]  

  • 51. Possible development of the serotonin syndrome in man.
    Insel TR; Roy BF; Cohen RM; Murphy DL
    Am J Psychiatry; 1982 Jul; 139(7):954-5. PubMed ID: 7091416
    [No Abstract]   [Full Text] [Related]  

  • 52. [A manic episode in a female patient with obsessive-compulsive disorder treated with chlorimipramine].
    Bernardo M; Vieta E; Vallejo J
    Med Clin (Barc); 1989 Oct; 93(10):395. PubMed ID: 2607791
    [No Abstract]   [Full Text] [Related]  

  • 53. Clomipramine-induced tourettism in obsessive-compulsive disorder: clinical and theoretical implications.
    Moshe K; Iulian I; Seth K; Eli L; Joseph Z
    Clin Neuropharmacol; 1994 Aug; 17(4):338-43. PubMed ID: 9316681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder.
    Austin LS; Lydiard RB; Ballenger JC; Cohen BM; Laraia MT; Zealberg JJ; Fossey MD; Ellinwood EH
    Biol Psychiatry; 1991 Aug; 30(3):225-32. PubMed ID: 1832972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suicidality with clomipramine.
    Harper G
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):369-70. PubMed ID: 1564041
    [No Abstract]   [Full Text] [Related]  

  • 56. Clomipramine for obsessive-compulsive symptoms.
    Szarek BL; Goethe JW
    Am J Psychiatry; 1988 Jul; 145(7):898-9. PubMed ID: 3289407
    [No Abstract]   [Full Text] [Related]  

  • 57. Clomipramine-induced urinary dysfunction in an obsessive-compulsive adolescent.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Munitz H
    Drug Intell Clin Pharm; 1987 Nov; 21(11):877-9. PubMed ID: 3678059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tricyclic response in obsessive compulsive disorder.
    Insel TR; Mueller EA; Gillin JC; Siever LJ; Murphy DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):25-31. PubMed ID: 3991911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melasma: A rare adverse effect of clomipramine.
    Kar SK
    Indian J Pharmacol; 2016; 48(4):453-454. PubMed ID: 27756961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obsessive-compulsive rituals.
    Marks I; Basoglu M
    Br J Psychiatry; 1989 Apr; 154():565-7. PubMed ID: 2686798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.